Intercept Pharmaceuticals, Inc. (ICPT) — Earnings Call X-Ray
Our AI read all 31 of ICPT's earnings calls (2016–2023) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
D
Q1 2023
Calls Analyzed
31
2016–2023
Avg Candor
5.7/9
evasion 4.7/9
Call-by-call analysis
🔒 Q2 2023 earnings call
2023-08-02
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q2 2023 call grade is ready
The full 37-point AI read of ICPT's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
D
Q1 2023 earnings call
2023-04-27
Management held guidance steady against steady demand and contracting margins. The delivery was rich in specifics.
Guidance: maintainedDemand: stableMargins: contractingHeadcount: flat 14 analysts · 22 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead⚑ Reads rehearsed
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
C
Q4 2022 earnings call
2023-03-02
Management held guidance steady against accelerating demand. The delivery was rich in specifics.
Guidance: maintainedDemand: acceleratingPricing: stableHeadcount: flat 13 analysts · 17 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Resolves doubts✓ Volume step-up ahead⚑ Reads rehearsed
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
B
Q3 2022 earnings call
2022-11-01
Management raised guidance against accelerating demand. The delivery was rich in specifics.
Guidance: raisedDemand: acceleratingMargins: stablePricing: stable 11 analysts · 25 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsed
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
C
Q2 2022 earnings call
2022-08-03
Management held guidance steady against accelerating demand. The delivery was rich in specifics, promotional in tone.
Guidance: maintainedDemand: acceleratingMargins: stable 9 analysts · 9 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsed
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
F
Q1 2022 earnings call
2022-05-06
Management withdrew guidance against mixed demand signals and expanding margins. The delivery was rich in specifics.
Guidance: withdrawnDemand: mixedMargins: expandingPricing: stableHeadcount: cutting 14 analysts · 22 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
F
Q4 2021 earnings call
2022-03-02
Management held guidance steady against steady demand and expanding margins. The delivery was rich in specifics.
Guidance: maintainedDemand: stableMargins: expandingPricing: stableHeadcount: flat 14 analysts · 22 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsed
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
D
Q3 2021 earnings call
2021-11-03
Management raised guidance against steady demand and expanding margins. The delivery was rich in specifics, frequently evasive.
Guidance: raisedDemand: stableMargins: expandingPricing: stableHeadcount: cutting 14 analysts · 15 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable⚑ Reads rehearsed
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q2 2021 |
2021-07-29 |
F |
maintained | mixed | unclear |
6/9 |
5/9 |
| Q1 2021 |
2021-05-06 |
F |
lowered | stable | expanding |
5/9 |
6/9 |
| Q4 2020 |
2021-02-25 |
F |
maintained | stable | expanding |
5/9 |
6/9 |
| Q3 2020 |
2020-11-09 |
F |
raised | stable | expanding |
6/9 |
5/9 |
| Q2 2020 |
2020-08-10 |
F |
lowered | stable | unclear |
5/9 |
6/9 |
| Q1 2020 |
2020-05-11 |
D |
maintained | mixed | unclear |
5/9 |
4/9 |
| Q4 2019 |
2020-02-25 |
D |
maintained | accelerating | contracting |
6/9 |
3/9 |
| Q3 2019 |
2019-11-05 |
D |
raised | stable | contracting |
6/9 |
4/9 |
| Q2 2019 |
2019-08-07 |
D |
maintained | accelerating | stable |
6/9 |
5/9 |
| Q1 2019 |
2019-05-08 |
C |
raised | accelerating | contracting |
6/9 |
4/9 |
| Q4 2018 |
2019-02-28 |
F |
maintained | accelerating | unclear |
6/9 |
5/9 |
| Q3 2018 |
2018-10-31 |
D |
maintained | stable | contracting |
5/9 |
6/9 |
| Q2 2018 |
2018-08-02 |
F |
maintained | stable | unclear |
6/9 |
5/9 |
| Q1 2018 |
2018-05-08 |
D |
none | slowing | contracting |
6/9 |
3/9 |
| Q4 2017 |
2018-02-14 |
F |
withdrawn | mixed | unclear |
6/9 |
4/9 |
| Q3 2017 |
2017-11-01 |
F |
maintained | mixed | contracting |
5/9 |
6/9 |
| Q2 2017 |
2017-07-31 |
C |
maintained | accelerating | unclear |
6/9 |
6/9 |
| Q1 2017 |
2017-05-04 |
C |
maintained | accelerating | unclear |
6/9 |
4/9 |
| Q4 2016 |
2017-02-23 |
F |
none | accelerating | unclear |
6/9 |
5/9 |
| Q3 2016 |
2016-11-03 |
F |
lowered | mixed | unclear |
6/9 |
5/9 |
| Q2 2016 |
2016-08-04 |
F |
maintained | stable | unclear |
6/9 |
6/9 |
| Q1 2016 |
2016-05-06 |
C |
maintained | unclear | unclear |
6/9 |
4/9 |
| Q4 2015 |
2016-02-23 |
D |
raised | unclear | contracting |
5/9 |
6/9 |
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← ICON All “I” companies
ICPW →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.